approval
saveCABENUVA KIT (CABOTEGRAVIR) — FDA approval
February 7, 2022updated 6mo ago
community read0 votes
Sponsor: VIIV HLTHCARE. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
view source ↗Data sources
last refreshed 6mo ago
Found something off?
same company · ±60 days · 6
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalJan 31, 2022
- approvalDOVATO (DOLUTEGRAVIR SODIUM) — FDA approvalJan 20, 2022
- approvalDOVATO (DOLUTEGRAVIR SODIUM) — FDA approvalJan 20, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalMar 23, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalMar 29, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalMar 29, 2022
comments(0)
5-min edit window · permanent after that